Task: Answer the multiple-choice question.
Question: Which compound exhibits a 1.452% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a Cl.Nc1cc(Cl)ccc1Oc1ccc(Cl)cc1
b O=C1NC(=O)C2(Cc3ccccc3N3CCCC32)C(=O)N1
c COc1ccc(Cl)cc1S(=O)(=O)N1CCN(c2ccc(F)cc2)CC1
Answer: b. O=C1NC(=O)C2(Cc3ccccc3N3CCCC32)C(=O)N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1NC(=O)C2(Cc3ccccc3N3CCCC32)C(=O)N1
O=C1NC(=O)C2(Cc3ccccc3N3CCCC32)C(=O)N1
spiro[1,3-diazinane-5,4'-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-a]quinoline]-2,4,6-trione